An important fraction of immune system cells necessary for effective immunisation against the SARS-CoV-2 pandemic virus has recently been the subject of new research.
A study has provided fresh information on a vital subset of immune system cells required for successful vaccination against the SARS-CoV-2 pandemic virus.
Even for killer T cells, which are specialised immune cells, searching for and eliminating cancer cells around the clock can be challenging. Scientists can produce stronger cancer-killing cells if they understand why killer T cells become exhausted.
Alzheimer's disease, a neurological disorder characterised with progressive cognitive decline, including memory loss, affects up to 5.8 million Americans today. Protein aggregates, made up of beta-amyloid or other proteins, occur in the brains of Alzheimer's patients. These beta-amyloid plaq
A recent study from the University of Michigan Department of Neurosurgery and Rogel Cancer Centre demonstrates encouraging preliminary findings that a therapy combining cell-killing and immune-stimulating drugs is safe and effective in extending survival for patients with gliomas, a particu
When combating disease, our immune cells must reach their target as rapidly as possible. Immune cells actively build their own navigation system to traverse across diverse settings, according to researchers at the Institute of Science and Technology Austria (ISTA). This challenges earlier no
The researchers shed light on the immune cells' capacity to collectively migrate through diverse environments in their work, which was published today in Science Immunology.
Researchers have proven the efficacy of vaccines they created to prevent the disfiguring skin illness leishmaniasis in animal experiments, and the most promising candidate is currently undergoing preparation for a Phase 1 human trial.
A recent study led by Karolinska Institutet researchers in Sweden investigated how weightlessness affects immune system T cells. The findings, published in the journal Science Advances, may explain why astronauts' T cells become less active and effective at fighting infection.
Boston [US]/Bangalore (Karnataka) [India], August 11: Zumutor Biologics Inc "Zumutor", a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today announces that the US Food and Drug Administration (FDA) has granted the company's In
Researchers at Monash University have discovered why some intestinal worm infections become chronic in animal models, which could lead to human vaccinations and better therapies.
Researchers have discovered a protein that is crucial to the operation of numerous novel cancer medicines. The discovery, according to the researchers, will probably help with efforts to optimize the use of immunotherapies against a number of difficult tumors.